Показано 0 из 0
Дата |
---|
19:58 |
02.07.2024 |
01.07.2024 |
28.06.2024 |
27.06.2024 |
26.06.2024 |
25.06.2024 |
24.06.2024 |
21.06.2024 |
20.06.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.92
|
1.97
|
1.90
|
1.71
|
2.0292
|
1.96
|
|
|
1 167 627.66
|
2 340.00
|
1.25
|
1.77
|
1.82
|
1.71
|
1.869
|
1.71
|
|
|
362 565.97
|
1 548.00
|
1.94
|
2.30
|
2.00
|
1.84
|
2.06
|
1.84
|
|
|
632 828.14
|
2 511.00
|
2.10
|
2.11
|
2.22
|
1.95
|
2.24
|
1.95
|
|
|
4 127 958.05
|
3 218.00
|
2.11
|
2.63
|
2.15
|
2.04
|
2.24
|
2.20
|
|
|
294 588.92
|
2 676.00
|
2.04
|
2.63
|
2.22
|
2.10
|
2.305
|
2.15
|
|
|
399 869.06
|
1 546.00
|
2.07
|
2.44
|
2.18
|
2.02
|
2.31
|
2.26
|
|
|
422 287.32
|
1 735.00
|
2.19
|
2.56
|
2.06
|
2.06
|
2.315
|
2.28
|
|
|
335 254.96
|
1 687.00
|
2.05
|
2.11
|
2.31
|
2.06
|
2.3568
|
2.06
|
|
|
483 416.20
|
2 535.00
|
2.27
|
2.28
|
2.43
|
2.22
|
2.46
|
2.28
|
|
|
455 808.32
|
1 673.00
|
Genelux Corporation operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a pipeline of next-generation oncolytic viral immunotherapies for patients suffering from cancers, including solid tumors.